Dowling & Yahnke’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
Other funds holding BBH
MCM
MJRIC
BRM
Dowling & Yahnke's BBH Position: Q1 2020 in Review
Dowling & Yahnke sold out of VanEck Biotech ETF (BBH) in Q1 2020, closing a stake of 815 shares — an estimated $114K sold.
Dowling & Yahnke first reported a position in BBH in Q4 2019 and held it in 1 quarter. The position peaked at $114K in Q4 2019. 83 funds tracked by Wall St. Rank hold BBH as of Q1 2020.
- Dowling & Yahnke reported no remaining VanEck Biotech ETF position as of Q1 2020 after selling out during the quarter.
- Dowling & Yahnke sold 815 VanEck Biotech ETF shares in Q1 2020, an estimated $114K.
- Dowling & Yahnke first reported a position in VanEck Biotech ETF in Q4 2019 and held it in 1 quarter.
- Dowling & Yahnke's VanEck Biotech ETF position peaked at $114K in Q4 2019.
- 83 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2020.
Based on Dowling & Yahnke's 13F filing for Q1 2020, filed 15 May 2020.